TY - JOUR
T1 - Mitochondrial diseases in North America
T2 - An analysis of the NAMDC Registry
AU - Barca, Emanuele
AU - Long, Yuelin
AU - Cooley, Victoria
AU - Schoenaker, Robert
AU - Emmanuele, Valentina
AU - Dimauro, Salvatore
AU - Cohen, Bruce H.
AU - Karaa, Amel
AU - Vladutiu, Georgirene D.
AU - Haas, Richard
AU - Van Hove, Johan L.K.
AU - Scaglia, Fernando
AU - Parikh, Sumit
AU - Bedoyan, Jirair K.
AU - Debrosse, Susanne D.
AU - Gavrilova, Ralitza H.
AU - Saneto, Russell P.
AU - Enns, Gregory M.
AU - Stacpoole, Peter W.
AU - Ganesh, Jaya
AU - Larson, Austin
AU - Zolkipli-Cunningham, Zarazuela
AU - Falk, Marni J.
AU - Goldstein, Amy C.
AU - Tarnopolsky, Mark
AU - Gropman, Andrea
AU - Camp, Kathryn
AU - Krotoski, Danuta
AU - Engelstad, Kristin
AU - Rosales, Xiomara Q.
AU - Kriger, Joshua
AU - Grier, Johnston
AU - Buchsbaum, Richard
AU - Thompson, John L.P.
AU - Hirano, Michio
N1 - Publisher Copyright:
© American Academy of Neurology.
PY - 2020
Y1 - 2020
N2 - ObjectiveTo describe clinical, biochemical, and genetic features of participants with mitochondrial diseases (MtDs) enrolled in the North American Mitochondrial Disease Consortium (NAMDC) Registry.MethodsThis cross-sectional, multicenter, retrospective database analysis evaluates the phenotypic and molecular characteristics of participants enrolled in the NAMDC Registry from September 2011 to December 2018. The NAMDC is a network of 17 centers with expertise in MtDs and includes both adult and pediatric specialists.ResultsOne thousand four hundred ten of 1,553 participants had sufficient clinical data for analysis. For this study, we included only participants with molecular genetic diagnoses (n = 666). Age at onset ranged from infancy to adulthood. The most common diagnosis was multisystemic disorder (113 participants), and only a minority of participants were diagnosed with a classical mitochondrial syndrome. The most frequent classical syndromes were Leigh syndrome (97 individuals) and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (71 individuals). Pathogenic variants in the mitochondrial DNA were more frequently observed (414 participants) than pathogenic nuclear gene variants (252 participants). Pathogenic variants in 65 nuclear genes were identified, with POLG1 and PDHA1 being the most commonly affected. Pathogenic variants in 38 genes were reported only in single participants.ConclusionsThe NAMDC Registry data confirm the high variability of clinical, biochemical, and genetic features of participants with MtDs. This study serves as an important resource for future enhancement of MtD research and clinical care by providing the first comprehensive description of participant with MtD in North America.
AB - ObjectiveTo describe clinical, biochemical, and genetic features of participants with mitochondrial diseases (MtDs) enrolled in the North American Mitochondrial Disease Consortium (NAMDC) Registry.MethodsThis cross-sectional, multicenter, retrospective database analysis evaluates the phenotypic and molecular characteristics of participants enrolled in the NAMDC Registry from September 2011 to December 2018. The NAMDC is a network of 17 centers with expertise in MtDs and includes both adult and pediatric specialists.ResultsOne thousand four hundred ten of 1,553 participants had sufficient clinical data for analysis. For this study, we included only participants with molecular genetic diagnoses (n = 666). Age at onset ranged from infancy to adulthood. The most common diagnosis was multisystemic disorder (113 participants), and only a minority of participants were diagnosed with a classical mitochondrial syndrome. The most frequent classical syndromes were Leigh syndrome (97 individuals) and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (71 individuals). Pathogenic variants in the mitochondrial DNA were more frequently observed (414 participants) than pathogenic nuclear gene variants (252 participants). Pathogenic variants in 65 nuclear genes were identified, with POLG1 and PDHA1 being the most commonly affected. Pathogenic variants in 38 genes were reported only in single participants.ConclusionsThe NAMDC Registry data confirm the high variability of clinical, biochemical, and genetic features of participants with MtDs. This study serves as an important resource for future enhancement of MtD research and clinical care by providing the first comprehensive description of participant with MtD in North America.
UR - https://www.scopus.com/pages/publications/85089524799
U2 - 10.1212/NXG.0000000000000402
DO - 10.1212/NXG.0000000000000402
M3 - Article
AN - SCOPUS:85089524799
SN - 2376-7839
VL - 6
JO - Neurology: Genetics
JF - Neurology: Genetics
IS - 2
M1 - e402
ER -